PUMA BIOTECHNOLOGY

puma-biotechnology-logo

Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.

#SimilarOrganizations #People #Financial #Website #More

PUMA BIOTECHNOLOGY

Social Links:

Industry:
Biotechnology Medical Therapeutics

Founded:
2010-01-01

Address:
Los Angeles, California, United States

Country:
United States

Website Url:
http://www.pumabiotechnology.com

Total Employee:
251+

Status:
Active

Contact:
310-443-4150

Email Addresses:
[email protected]

Total Funding:
809.3 M USD

Technology used in webpage:
SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

scholar-rock-logo

Scholar Rock

Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.


Current Advisors List

ann-miller_image

Ann Miller Member Board of Directors @ Puma Biotechnology
Board_member
2019-11-01

troy-wilson_image

Troy Wilson Board Member @ Puma Biotechnology
Board_member

Current Employees Featured

gordon-esplin_image

Gordon Esplin
Gordon Esplin VP Finance @ Puma Biotechnology
VP Finance
2020-10-01

not_available_image

Charles Eyler
Charles Eyler Senior Vice President, Finance and Administration and Treasurer @ Puma Biotechnology
Senior Vice President, Finance and Administration and Treasurer

alan-h-auerbach_image

Alan H. Auerbach
Alan H. Auerbach Chief Executive Officer & President @ Puma Biotechnology
Chief Executive Officer & President
2010-01-01

Founder


alan-h-auerbach_image

Alan H. Auerbach

Stock Details


Company's stock symbol is NASDAQ:PBYI

Investors List

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Equity - Puma Biotechnology

alan-h-auerbach_image

Alan H. Auerbach

Alan H. Auerbach investment in Post-IPO Equity - Puma Biotechnology

armentum-partners_image

Armentum Partners

Armentum Partners investment in Post-IPO Debt - Puma Biotechnology

athyrium-capital-management_image

Athyrium Capital Management LP

Athyrium Capital Management LP investment in Post-IPO Debt - Puma Biotechnology

silicon-valley-bank_image

Silicon Valley Bank

Silicon Valley Bank investment in Post-IPO Equity - Puma Biotechnology

oxford-finance-corporation_image

Oxford Finance LLC

Oxford Finance LLC investment in Post-IPO Equity - Puma Biotechnology

orbimed-advisors_image

OrbiMed

OrbiMed investment in Post-IPO Equity - Puma Biotechnology

sahsen-ventures_image

Sahsen Ventures

Sahsen Ventures investment in Post-IPO Equity - Puma Biotechnology

h-q-healthcare-investors_image

H&Q Healthcare Investors

H&Q Healthcare Investors investment in Post-IPO Equity - Puma Biotechnology

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Post-IPO Equity - Puma Biotechnology

Official Site Inspections

http://www.pumabiotechnology.com Semrush global rank: 4.23 M Semrush visits lastest month: 2.78 K

  • Host name: 33.187.62.50.host.secureserver.net
  • IP address: 50.62.187.33
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Puma Biotechnology" on Search Engine